A Study to Evaluate if Siddha Medicine Can help reduce Weight and Body Measurements in People with Moderate Obesity Over 90 Days

An open-labelled, single-centric, randomized prospective clinical trial for evaluating the therapeutic efficacy of a Siddha regimen in the management of Atitula noy, Obesity, Class I and Class II - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088766

Enrollment

Registered

2025-06-12

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

Intervention1: Thiripala Chooranam Nerunjil Kudineer Jalamanjari Chenduram: Thiripala Chooranam(poly herbal powder) Nerunjil Kudineer(poly herbal decoction) Jalamanjari Chenduram(herbo-mineral drug) A

Eligibility

Inclusion criteria

Inclusion criteria: K/C/O Diabetes Mellitus Obesity-BMI greater than or equal to 30kg/m^2 Obesity class l-BMI 30 to 34.9kg/m^2 Obesity class ll-BMI 35 to 39.9kg/m^2

Exclusion criteria

Exclusion criteria: Vulnerable groups (Pregnancy and lactation) Hypothyroidism Malignancy

Design outcomes

Primary

Measure	Time frame
A 5 to 10 percent reduction in BMI and a reduction in anthropometric measurements from baseline to endpoint. Timepoint: 90 days	—

Secondary

Measure	Time frame
To assess the difference in laboratory parameters and Enhanced Quality of Life from baseline to endpointTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDr G Senthilvel

National institute of siddha

siddha.senthilvel@gmail.com8925856333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026